Attana AB (publ) (NGM:ATANA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0110
+0.0020 (22.22%)
At close: Dec 5, 2025
-47.62%
Market Cap 21.12M
Revenue (ttm) 6.13M
Net Income (ttm) -10.90M
Shares Out 1.92B
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 24,009,935
Average Volume 19,593,994
Open n/a
Previous Close 0.0090
Day's Range n/a
52-Week Range 0.0050 - 0.0350
Beta 1.06
RSI 36.97
Earnings Date Feb 24, 2026

About Attana AB

Attana AB (publ) provides analytical instruments and services for validating, selecting, and optimizing drug candidates primarily in Sweden. The company offers contract research services; in vitro diagnostic tools; analytical instruments; and Attana virus analytics. It serves pharmaceutical and biotechnology companies, and academic institutions. Attana AB (publ) was founded in 2002 and is headquartered in Sollentuna, Sweden. [Read more]

Industry Commercial Physical and Biological Research
Founded 2002
Employees 6
Stock Exchange Nordic Growth Market
Ticker Symbol ATANA
Full Company Profile

Financial Performance

In 2024, Attana AB's revenue was 6.61 million, a decrease of -3.02% compared to the previous year's 6.82 million. Losses were -12.78 million, -7.33% less than in 2023.

Financial Statements

News

There is no news available yet.